Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.46 USD | +0.02% | -4.17% | -61.67% |
Apr. 02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
Mar. 19 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
Sales 2023 * | 48.62M 51.96M | Sales 2024 * | 59.5M 63.58M | Capitalization | 11.96M 12.78M |
---|---|---|---|---|---|
Net income 2023 * | -48M -51.29M | Net income 2024 * | -45M -48.09M | EV / Sales 2023 * | 0.25 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.2 x |
P/E ratio 2023 * |
-0.27
x | P/E ratio 2024 * |
-0.44
x | Employees | 444 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.49% |
1 day | +1.98% | ||
1 week | -4.17% | ||
Current month | -35.21% | ||
1 month | -35.21% | ||
3 months | -60.34% | ||
6 months | -57.50% | ||
Current year | -61.67% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Stratton
CEO | Chief Executive Officer | 62 | 21-12-19 |
Director of Finance/CFO | - | 22-02-07 | |
Chief Tech/Sci/R&D Officer | 64 | 21-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peer Schatz
CHM | Chairman | 57 | 20-03-15 |
Hubert Birner
BRD | Director/Board Member | 57 | 17-06-30 |
Flemming Ørnskov
BRD | Director/Board Member | 66 | 19-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.46 | +0.02% | 6 254 |
24-04-29 | 0.4599 | -5.93% | 74,991 |
24-04-26 | 0.4889 | +1.88% | 6,941 |
24-04-25 | 0.4799 | +4.10% | 7,168 |
24-04-24 | 0.461 | -3.96% | 19,900 |
Delayed Quote Nasdaq, April 30, 2024 at 11:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.67% | 12.82M | |
+0.81% | 42.86B | |
+12.53% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+6.46% | 25.15B | |
-23.58% | 18.63B | |
+29.19% | 12.37B | |
-3.20% | 11.92B | |
+7.06% | 11.21B |
- Stock Market
- Equities
- CNTG Stock